Cells predict onset of graft-versus-host disease in men receiving BMTs from ... EurekAlert (press release) Miklos and his associates have shown in other studies that an injectable drug called rituximab (itself an antibody) that attacks B cells while sparing other immune-cell types can reduce the incidence of cGVHD in female-to-male-transplant recipients ... |
